Literature DB >> 23217676

Impacts of duration of untreated psychosis on cognition and negative symptoms in first-episode schizophrenia: a 3-year prospective follow-up study.

W C Chang1, C L M Hui, J Y M Tang, G H Y Wong, S K W Chan, E H M Lee, E Y H Chen.   

Abstract

BACKGROUND: Cognitive impairment is a core feature of schizophrenia. Its relationship with duration of untreated psychosis (DUP), a potentially malleable prognostic factor, has been less studied, with inconsistent findings being observed in the literature. Previous research investigating such a relationship was mostly cross-sectional and none of those prospective studies had a follow-up duration beyond 2 years. Method A total of 93 Hong Kong Chinese aged 18 to 55 years presenting with first-episode schizophrenia-spectrum disorder were studied. DUP and pre-morbid adjustment were measured using a structured interview incorporating multiple sources of information. Psychopathological evaluation was administered at intake, after clinical stabilization of the first psychotic episode, and at 12, 24 and 36 months. Cognitive functions were measured at clinical stabilization, and at 12, 24 and 36 months.
RESULTS: DUP exerted differential effects on various cognitive domains, with memory deficits being the most related to DUP even when potential confounders including pre-morbid adjustment and sex were adjusted. Prolonged DUP was associated with more severe impairment in visual memory at clinical stabilization and verbal memory at 24 and 36 months. Further, patients with a long DUP were found to have worse outcomes on negative symptoms at 36 months. The effects of DUP on verbal memory remained significant even when negative symptoms were taken into consideration.
CONCLUSIONS: Our findings provided further supportive evidence that delayed treatment to first-episode psychosis is associated with poorer cognitive and clinical outcomes. In addition, DUP may specifically affect memory function and its adverse impact on verbal memory may only become evident at a later stage of the recovery process.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23217676     DOI: 10.1017/S0033291712002838

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  13 in total

Review 1.  What does schizophrenia teach us about antipsychotics?

Authors:  Gary Remington; Ofer Agid; George Foussias; Gagan Fervaha; Hiroyoshi Takeuchi; Jimmy Lee; Margaret Hahn
Journal:  Can J Psychiatry       Date:  2015-03       Impact factor: 4.356

2.  Negative symptoms in first episode schizophrenia: treatment response across the 2-year follow-up of the "Parma Early Psychosis" program.

Authors:  Lorenzo Pelizza; Emanuela Leuci; Davide Maestri; Emanuela Quattrone; Silvia Azzali; Giuseppina Paulillo; Pietro Pellegrini
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-01-28       Impact factor: 5.270

3.  From Memories of Past Experiences to Present Motivation? A Meta-analysis on the Association Between Episodic Memory and Negative Symptoms in People With Psychosis.

Authors:  Matthias Pillny; Katarina Krkovic; Laura Buck; Tania M Lincoln
Journal:  Schizophr Bull       Date:  2022-03-01       Impact factor: 7.348

4.  The Prodromal Questionnaire: a case for IRT-based adaptive testing of psychotic experiences?

Authors:  Jan van Bebber; Johanna T W Wigman; Rob R Meijer; Helga K Ising; David van den Berg; Judith Rietdijk; Sara Dragt; Rianne Klaassen; Dorien Nieman; Peter de Jonge; Sjoerd Sytema; Marieke Wichers; Don Linszen; Mark van der Gaag; Lex Wunderink
Journal:  Int J Methods Psychiatr Res       Date:  2016-07-29       Impact factor: 4.035

5.  Motivational deficits in individuals at-risk for psychosis and across the course of schizophrenia.

Authors:  Danielle A Schlosser; Melissa Fisher; David Gard; Daniel Fulford; Rachel L Loewy; Sophia Vinogradov
Journal:  Schizophr Res       Date:  2014-07-05       Impact factor: 4.939

6.  Duration of untreated psychosis is associated with temporal and occipitotemporal gray matter volume decrease in treatment naïve schizophrenia.

Authors:  Xiaofeng Guo; Jun Li; Qinling Wei; Xiaoduo Fan; David N Kennedy; Yidong Shen; Huafu Chen; Jingping Zhao
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

7.  Design and Methodology of the Korean Early Psychosis Cohort Study.

Authors:  Sung-Wan Kim; Bong Ju Lee; Jung Jin Kim; Je-Chun Yu; Kyu Young Lee; Seung-Hee Won; Seung-Hwan Lee; Seung-Hyun Kim; Shi Hyun Kang; Young-Chul Chung
Journal:  Psychiatry Investig       Date:  2016-12-29       Impact factor: 2.505

8.  Effects of Group Cognitive-Behavioral Therapy in Young Patients in the Early Stage of Psychosis.

Authors:  Sung-Wan Kim; Ji-Eun Jang; Ju-Yeon Lee; Ga-Young Lee; Hye-Young Yu; Cheol Park; Hee-Ju Kang; Jae-Min Kim; Jin-Sang Yoon
Journal:  Psychiatry Investig       Date:  2017-09-11       Impact factor: 2.505

Review 9.  Advancing study of cognitive impairments for antipsychotic-naïve psychosis comparing high-income versus low- and middle-income countries with a focus on urban China: Systematic review of cognition and study methodology.

Authors:  Lawrence H Yang; Bernalyn Ruiz; Amar D Mandavia; Margaux M Grivel; Liang Y Wong; Michael R Phillips; Matcheri S Keshavan; Huijun Li; Jeffrey A Lieberman; Ezra Susser; Larry J Seidman; William S Stone
Journal:  Schizophr Res       Date:  2020-04-05       Impact factor: 4.939

10.  Development of Chinese mental health first aid guidelines for psychosis: a Delphi expert consensus study.

Authors:  Wenjing Li; Anthony F Jorm; Yan Wang; Shurong Lu; Yanling He; Nicola Reavley
Journal:  BMC Psychiatry       Date:  2020-09-10       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.